Description
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 3/06: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics
Class A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
Subclass 3/06: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) Antihyperlipidemics
Patent # | Title | Filing Date | Issue Date | Patent Owner |
---|---|---|---|---|
12257217 | Compositions and methods for treating hyperphagia in prader-willi syndrome | Oct 15, 22 | Mar 25, 25 | Purdue Research Foundation |
RE50320 | APOE mimetic peptides and higher potency to clear plasma cholesterol | May 19, 22 | Mar 04, 25 | The UAB Research Foundation; Anji Pharmaceuticals Inc.; |
12239620 | Methods to decrease triglyceride synthesis in the liver | May 26, 22 | Mar 04, 25 | Medicinova, Inc. |
12239663 | Pharmaceutical composition for prevention or treatment of lysosomal storage disorders | Jan 23, 20 | Mar 04, 25 | BIOGRAPHENE INC.; Seoul National University R&DB Foundation; |
12239674 | LRH05 isolate, and composition including the same and use thereof | Jun 17, 21 | Mar 04, 25 | SYNBIO TECH INC. |
12239683 | Synergistic hepatoprotective composition | Apr 18, 19 | Mar 04, 25 | FFF BIOWORKS LLP |
12233044 | Cannabidiol and chitosan compositions and methods of using the same | Nov 08, 22 | Feb 25, 25 | MOR RESEARCH APPLICATIONS LTD |
12233098 | water-insoluble dietary fiber | Sep 11, 20 | Feb 25, 25 | University of Shanghai for Science and Technology |
12226423 | Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide | Jun 28, 22 | Feb 18, 25 | Virginia Commonwealth University; Durect Corporation; The United States Government as Represented by the Department of Veterans Affairs; |
12226442 | oil and surface-active agents | Nov 07, 19 | Feb 18, 25 | N.S. OILS LTD. |
12221426 | Inhibitory material against human body-derived nicotinamide adenine dinucleotide phosphate-dependent steroid dehydrogenase-like, and anticancer agent comprising same as effective ingredient or pharmaceutical composition comprising same as effective ingredient for treatment of hyperlipidemia | Aug 29, 19 | Feb 11, 25 | Seoul National University R&DBFoundation; Korea Research Institute of Chemical Technology; National Cancer Center; |
12209145 | PCSK9 antagonist compounds | Jun 30, 22 | Jan 28, 25 | Merck Sharp & Dohme LLC |
12202809 | Benzothia(di)azepine compounds and their use as bile acid modulators | Jun 02, 23 | Jan 21, 25 | Albireo AB |
12187724 | Pyrazolopyridine derivative having GLP-1 receptor agonist effect | Aug 11, 23 | Jan 07, 25 | Chugai Seiyaku Kabushiki Kaisha |
12178842 | PCSK9 antagonist compounds | Oct 31, 22 | Dec 31, 24 | Merck Sharp & Dohme LLC |
12171738 | Compositions and methods for lowering triglycerides | Aug 10, 22 | Dec 24, 24 | AMARIN PHARMACEUTICALS IRELAND LIMITED |
12150975 | Therapeutic combinations to treat red blood cell disorders | Jul 26, 17 | Nov 26, 24 | HARTIS-PHARMA SA |
12138285 | Cholesterol reducing compositions and methods of use thereof | Mar 06, 23 | Nov 12, 24 | Not available |
12139497 | Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders | Mar 21, 23 | Nov 12, 24 | Achillion Pharmaceuticals, Inc. |
12134636 | Immunoglobulins and uses thereof | Oct 30, 20 | Nov 05, 24 | Janssen Pharmaceutica NV |
Publication # | Title | Filing Date | Pub Date | Patent Owner |
---|---|---|---|---|
2025/0114,415 | METHOD FOR LOWERING CHOLESTEROL AND LIPID LEVELS USING THE ANTRODIA CINNAMOMEA WATER-INSOLUBLE DIETARY FIBER | Dec 20, 24 | Apr 10, 25 | Not available |
2025/0092,041 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | Nov 22, 24 | Mar 20, 25 | Chugai Seiyaku Kabushiki Kaisha |
2025/0082,706 | FERMENTED GINSENG RADIX ET RHIZOMA EXTRACT, PRODUCT FOR ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE, METHOD FOR PROMOTING INCREASE OF CONTENT OF AGLYCONE FLAVONOIDS AND/OR SHORT-CHAIN FATTY ACIDS IN GINSENG RADIX ET RHIZOMA EXTRACT, AND METHOD FOR PROMOTING EFFICACY OF GINSENG RADIX ET RHIZOMA EXTRACT IN ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE | Jun 18, 24 | Mar 13, 25 | INFINITUS (CHINA) COMPANY LTD. |
2025/0073,185 | Composition Including Benzylaminoethanol Derivative as Active Ingredient for Prevention or Treatment of Metabolic Disease | Jul 28, 22 | Mar 06, 25 | Not available |
2025/0064,926 | HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS | Jul 31, 24 | Feb 27, 25 | Not available |
2025/0066,509 | ANTI-BETAKLOTHO ANTIBODY AND USE THEREOF | Dec 29, 22 | Feb 27, 25 | Not available |
2025/0059,300 | METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODY | Jul 29, 24 | Feb 20, 25 | Not available |
2025/0059,540 | DOUBLE STRANDED RNA TARGETING ANGIOPOIETIN-LIKE 3 (ANGPTL-3) AND METHODS OF USE THEREOF | Jun 28, 24 | Feb 20, 25 | Not available |
2025/0051,765 | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | Apr 29, 24 | Feb 13, 25 | Not available |
2025/0051,457 | ASGR INHIBITORS | Jul 11, 24 | Feb 13, 25 | Not available |
2025/0041,264 | METHOD FOR TREATING DIABETES BY USING ANTRODIA CAMPHORATA COMPOUND | Jan 24, 24 | Feb 06, 25 | Not available |
2025/0032,446 | METHODS AND COMPOSITIONS FOR THE BIOSYNTHESIS AND USE OF DEMETHYLATED POLYMETHOXY FLAVONES | Dec 12, 22 | Jan 30, 25 | Board of Trustees Rutgers The State University of New Jersey |
2025/0025,421 | PREPARATION IN SOLID FORM COMPRISING ACTIVATED CARBON AND CHITOSAN, METHOD FOR PREPARING SAID PREPARATION, COMPOSITION COMPRISING SAID PREPARATION AND USES OF SAID COMPOSITION | Jun 10, 22 | Jan 23, 25 | Not available |
2025/0025,538 | METHODS FOR TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS | Aug 08, 24 | Jan 23, 25 | Not available |
2025/0026,803 | IMMUNOGLOBULINS AND USES THEREOF | Oct 02, 24 | Jan 23, 25 | Not available |
2025/0027,089 | DOUBLE STRANDED RNA TARGETING PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) AND METHODS OF USE THEREOF | Jun 21, 24 | Jan 23, 25 | Not available |
2025/0017,998 | SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM | Jul 03, 24 | Jan 16, 25 | Not available |
2025/0019,353 | BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS | Jul 02, 24 | Jan 16, 25 | Not available |
2025/0009,840 | CHOLESTEROL-FREE HIGH-DENSITY LIPOPROTEIN PARTICLES | Oct 04, 22 | Jan 09, 25 | PhoenixBio Co., Ltd. |
2025/0009,842 | Methods for Regulating Muscle Performance using Fat Specific Protein 27 (FSP27) Compositions | Aug 13, 24 | Jan 09, 25 | Ohio University |
Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
---|